Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

International journal of cancer·2026
Same author

Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders.

Pediatrics·2026
Same author

Chiral Microneedle Arrays With Terahertz Chiroptical Activity With Chiral-Plasmon-Chiral-Phonon Resonance.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Oral oncology·2026
Same author

Gas vesicle-expressing human pluripotent stem cells enable multimodal ultrasound and optical coherence tomographic imaging.

BMC biotechnology·2026
Same journal

Differentiated service delivery and self-care in HIV.

The lancet. HIV·2026
Same journal

Risk of donor-driven stigma in scale-up of long-acting PrEP.

The lancet. HIV·2026
Same journal

Achieving 95-95-95 outcomes: it takes a couple.

The lancet. HIV·2026
Same journal

Effectiveness of interventions to promote couples-based HIV testing and family health during pregnancy and postpartum in Kenya: a multicentre, couples-based, randomised controlled trial.

The lancet. HIV·2026
Same journal

Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling study.

The lancet. HIV·2026
Same journal

Global HIV response requires global political support.

The lancet. HIV·2026
See all related articles

Related Experiment Video

Updated: Dec 12, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.0K

Modern diagnostic technologies for HIV.

Nitika Pant Pai1, Angela Karellis1, John Kim2

  • 1Department of Medicine, McGill University, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

The Lancet. HIV
|August 9, 2020
PubMed
Summary
This summary is machine-generated.

Novel diagnostic technologies like AI and genomics can help achieve global HIV targets. These advanced methods offer accurate, rapid, and easy HIV detection, aiding in epidemic control.

More Related Videos

Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
07:24

Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection

Published on: October 29, 2020

3.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K

Related Experiment Videos

Last Updated: Dec 12, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.0K
Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection
07:24

Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection

Published on: October 29, 2020

3.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K

Area of Science:

  • Biotechnology
  • Medical Diagnostics
  • Public Health

Background:

  • Biomarker-based rapid tests, particularly antibody tests, have been the standard for HIV diagnostics since the 1980s.
  • Achieving the UNAIDS 95-95-95 targets requires innovative approaches to HIV diagnosis and epidemic control.
  • Current diagnostic methods face challenges in early detection and widespread accessibility.

Purpose of the Study:

  • To explore how novel diagnostic technologies can contribute to meeting the UNAIDS 95-95-95 targets.
  • To highlight the potential of emerging technologies in improving HIV diagnosis and epidemic control.
  • To discuss the advantages and challenges associated with the global deployment of these new technologies.

Main Methods:

  • Review of emerging diagnostic technologies including nanotechnology, microfluidics, -omics science, next-generation sequencing, genomics big data, and machine learning.
  • Examination of multiplexed technologies, biomarker-based combination antibody and antigen tests, dried-blood-spot testing, and self-testing.
  • Analysis of the application of nucleic acid and gene targets in nanomedicine, biosensors, and microfluidics for early HIV detection.

Main Results:

  • Novel technologies demonstrate potential for early HIV diagnosis through the detection of nucleic acids and genes.
  • These advanced methods offer advantages such as ease of use, high diagnostic accuracy, and rapid detection.
  • Technologies like multiplexed assays and point-of-care tests show promise for widespread application.

Conclusions:

  • Emerging diagnostic technologies are crucial for achieving the UNAIDS 95-95-95 targets and controlling the HIV epidemic.
  • Further clinical and implementation research is necessary to validate and optimize the use of these novel tools.
  • A public health strategy is essential to overcome challenges and ensure the global deployment of advanced HIV diagnostics.